Intermediate Capital Group
Hedge fund
Active
London, United Kingdom
29
73M
26
0.83
15
0.07
6
- Stages of investment
- Areas of investment
Summary
In 1989 was created Intermediate Capital Group, which is appeared as VC. The venture was found in Europe in United Kingdom. The main department of described VC is located in the London.
The typical case for the fund is to invest in rounds with 1-2 participants. Despite the Intermediate Capital Group, startups are often financed by HgCapital Trust plc, Ardian. The meaningful sponsors for the fund in investment in the same round are HgCapital Trust plc, Goldman Sachs Asset Management.
Besides, a startup requires to be at the age of more than 20 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Vitaldent, IRIS Software Group For fund there is a match between the location of its establishment and the land of its numerous investments - United Kingdom. We can highlight the next thriving fund investment areas, such as Robotics, Forestry.
Comparing to the other companies, this Intermediate Capital Group performs on 21 percentage points more the average number of lead investments. Deals in the range of more than 100 millions dollars are the general things for fund. The important activity for fund was in 2013. The increased amount of exits for fund were in 2019. Speaking about the real fund results, this VC is 80 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year.
This organization was formed by Ken Fox, Thomas H. Bartlam. The overall number of key employees were 13.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 29
- Lead investments
- 15
- Exits
- 6
- Rounds per year
- 0.83
- Follow on index
- 0.07
- Investments by industry
- Health Care (5)
- Biotechnology (4)
- Pharmaceutical (3)
- Software (3)
- Information Technology (3) Show 46 more
- Investments by region
-
- United States (7)
- France (3)
- India (1)
- United Kingdom (8)
- Spain (2) Show 5 more
- Peak activity year
- 2021
- Number of Unicorns
- 2
- Number of Decacorns
- 2
- Number of Minotaurs
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 26
- Avg. valuation at time of investment
- 157M
- Group Appearance index
- 0.45
- Avg. company exit year
- 18
- Avg. multiplicator
- 0.39
- Strategy success index
- 0.20
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Grey Wolf Therapeutics | 23 May 2024 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 50M | England, Oxford, United Kingdom |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.